Salipro Biotech’s global patent estate now includes over 60 granted patents spanning the U.S., EU, China, Japan, Australia, Singapore, and other major life-science markets. Together, these patents protect the core elements of the Salipro^® technology, which stabilizes membrane proteins in their native lipid environment to deliver high-quality functional targets for small-molecule drug discovery, biologics development as well as structure-based drug design.